Total Pageviews

4/16/2011

QUIETPRO+ Intelligent Hearing System

http://www.nacre.no/quietpro-pluss.asp


FLEXIBLE RADIO AND INTERCOM INTERFACE
A new software programmable, binaural interface for user defined stereo or split ear capabilities. Compatible with all current and future communication systems.
EXTENDED FUNCTIONALITY
A selectable ‘whisper’ mode that enables extended use in low noise operations.
INCREASED USER CONTROL - DUAL CHANNEL WIRELESS PTT
Up to 5 wireless PTT remote control devices can be simultaneously used with a QUIETPRO+ system. Optional wired PTT controls are also available.
QUALIFIED AND APPROVED
Following extensive testing and evaluation during 2008, the QUIETPRO® is the only in-ear communications device approved for use by the US Army.
THE QUIETPRO+ IS AVAILABLE TODAY!
Contact us to request your demonstration and evaluation units.
QP+ system

1 comment:

  1. Neurofibromatosis treatment AR-42

    Arno Medical treatment of type 2 multiple neurofibroma Drug AR-42 issued by the European Commission recently received orphan drug designation accreditation. AR-42 is a suitable non-histones and histone deacetylase inhibitors spectrum.

    In preclinical studies, such oral inhibitor of the entity in the treatment of tumors and hematological malignancies shows good efficacy and activity.

    The ongoing Phase AR-42 Ⅰ, Ⅱ a period of research, mainly for multiple hematologic malignancies and solid tumors.



    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    ENMD-2076 TARTARIC ACID
    ENMD-2076
    SNS-314
    CCT129202
    Hesperadin
    PF-03814735
    AT9283
    GSK-1070916
    MK-5108
    Aurora A inhibitor I

    ReplyDelete